Funding source: University of Liège http://dx.doi.org/10.13039/501100005627
-
Research funding: This study was supported by Clinical Chemistry Department and University of Liège.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The blood collection was approved by local Ethical Committee (reference: 2021/3).
References
1. Vanderstichele, H, Bibl, M, Engelborghs, S, Le Bastard, N, Lewczuk, P, Molinuevo, JL, et al.. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s Biomarkers Standardization Initiative. Alzheimers Dement 2012;8:65–73. https://doi.org/10.1016/j.jalz.2011.07.004.Search in Google Scholar
2. Lewczuk, P, Beck, G, Esselmann, H, Bruckmoser, R, Zimmermann, R, Fiszer, M, et al.. Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides. Clin Chem 2006;52:332–4. https://doi.org/10.1373/clinchem.2005.058776.Search in Google Scholar
3. Pica-Mendez, AM, Tanen, M, Dallob, A, Tanaka, W, Laterza, OF. Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20. Clin Chim Acta 2010;411:1833. https://doi.org/10.1016/j.cca.2010.07.019.Search in Google Scholar
4. Mille, C, Debarnot, D, Zorzi, W, El Moualij, B, Coudreuse, A, Legeay, G, et al.. Improvement of the detection of neurodegenerative Alzheimer’s disease through a specific surface chemistry applied onto the inner surface of the titration well. J Biomater Sci Polym Ed 2012;23:1951–61. https://doi.org/10.1163/092050611x600712.Search in Google Scholar
5. Perret-Liaudet, A, Pelpel, M, Tholance, Y, Dumont, B, Vanderstichele, H, Zorzi, W, et al.. Risk of Alzheimer’s disease biological misdiagnosis linked to cerebrospinal collection tubes. J Alzheimers Dis 2012;31:13–20. https://doi.org/10.3233/jad-2012-120361.Search in Google Scholar
6. Keshavan, A, Heslegrave, A, Zetterberg, H, Schott, JM. Stability of blood-based biomarkers of Alzheimer’s disease over multiple freeze-thaw cycles. Alzheimers Dement 2018;2:448–51. https://doi.org/10.1016/j.dadm.2018.06.001.Search in Google Scholar
7. Lachno, DR, Vanderstichele, H, de Groote, G, Kostanjevecki, V, de Meyer, G, Siemers, ER, et al.. The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma β-amyloid isoforms using the INNO-BIA plasma AB forms multiplex assay. J Nutr Health Aging 2009;13:220–5. https://doi.org/10.1007/s12603-009-0062-5.Search in Google Scholar
8. Rózga, M, Bittner, T, Batrla, R, Karl, J. Preanalytical sample handling recommendations for Alzheimer’s disease plasma biomarkers. Alzheimers Dement 2019;2:291–300. https://doi.org/10.1016/j.dadm.2019.02.002.Search in Google Scholar
9. Hansson, O, Mikulskis, A, Fagan, AM, Teunissen, C, Zetterberg, H, Vanderstichele, H, et al.. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer’s disease diagnosis: a review. Alzheimers Dement 2018;14:1313–33. https://doi.org/10.1016/j.jalz.2018.05.008.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
